Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1957 1
1963 1
1966 1
1967 1
1973 2
1974 3
1975 4
1976 1
1977 2
1980 1
1981 5
1982 6
1983 4
1984 3
1985 2
1986 2
1990 1
1991 1
1992 2
1993 1
1994 4
1995 6
1996 4
1997 7
1998 5
1999 1
2000 8
2001 4
2002 2
2003 4
2004 8
2005 3
2006 1
2007 6
2008 2
2009 2
2010 5
2011 5
2012 5
2013 7
2014 5
2015 6
2016 9
2017 6
2018 1
2019 1
2020 1
2021 7
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Rummel MJ, et al. Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20. Lancet. 2013. PMID: 23433739 Clinical Trial.
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.
Amato AA, Hanna MG, Machado PM, Badrising UA, Chinoy H, Benveniste O, Karanam AK, Wu M, Tankó LB, Schubert-Tennigkeit AA, Papanicolaou DA, Lloyd TE, Needham M, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Aoki M, Katsuno M, Morihata H, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Zhang Auberson L; RESILIENT Study Extension Group. Amato AA, et al. Neurology. 2021 Mar 23;96(12):e1595-e1607. doi: 10.1212/WNL.0000000000011626. Epub 2021 Feb 17. Neurology. 2021. PMID: 33597289 Free PMC article. Clinical Trial.
The immunology of tumors.
Burk MW, Mckhann CF. Burk MW, et al. Surg Annu. 1973;5:1-29. Surg Annu. 1973. PMID: 4602210 Review. No abstract available.
ASHP Guidelines on Medication-Use Evaluation.
Afanasjeva J, Burk M, Cunningham FF, Fanikos J, Gabay M, Hayes GJ, Masters PL, Rodriguez R, Sinnett MJ. Afanasjeva J, et al. Among authors: burk m. Am J Health Syst Pharm. 2021 Jan 5;78(2):168-175. doi: 10.1093/ajhp/zxaa393. Am J Health Syst Pharm. 2021. PMID: 33399190 No abstract available.
The scientific method.
Burk M. Burk M. Science. 1986 Feb 14;231(4739):659. doi: 10.1126/science.231.4739.659. Science. 1986. PMID: 17800786 No abstract available.
An integrated biotechnology platform for developing sustainable chemical processes.
Barton NR, Burgard AP, Burk MJ, Crater JS, Osterhout RE, Pharkya P, Steer BA, Sun J, Trawick JD, Van Dien SJ, Yang TH, Yim H. Barton NR, et al. Among authors: burk mj. J Ind Microbiol Biotechnol. 2015 Mar;42(3):349-60. doi: 10.1007/s10295-014-1541-1. Epub 2014 Nov 22. J Ind Microbiol Biotechnol. 2015. PMID: 25416472 Review.
Synthesis and Biological Evaluation of (2S,2'S)-Lomaiviticin A.
Kaneko M, Li Z, Burk M, Colis L, Herzon SB. Kaneko M, et al. Among authors: burk m. J Am Chem Soc. 2021 Jan 20;143(2):1126-1132. doi: 10.1021/jacs.0c11960. Epub 2021 Jan 7. J Am Chem Soc. 2021. PMID: 33410680 Free PMC article.
166 results